Skip navigation

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Results 1 - 10 of 16 for ZANUBRUTINIB
  1. Zanubrutinib 
    Zanubrutinib is used to treat mantle cell lymphoma (MCL; a fast-growing cancer that begins in the ... treated with at least one other chemotherapy medication. Zanubrutinib is also used to treat adults with Waldenstrom's ...
    https://medlineplus.gov/druginfo/meds/a620009.html - Drugs and Supplements
  2. Advances in Leukemia Research From the National Institutes of Health (National Cancer Institute)  
    Find out what's new in current leukemia research including progress on targeted therapies and immunotherapies, and NCI programs and clinical trials. ... Acute ...
    https://www.cancer.gov/types/leukemia/research - External Health Links
  3. Treatment Option Overview (Chronic Lymphocytic Leukemia) From the National Institutes of Health (National Cancer Institute)  
    Chronic Lymphocytic Leukemia/Treatments and Therapies ... Chronic Lymphocytic Leukemia ... National Cancer Institute ... Chronic lymphocytic leukemia (CLL) treatment ...
    https://www.cancer.gov/types/leukemia/patient/cll-treatment-pdq#_48 - External Health Links
  4. Stage Information for Chronic Lymphocytic Leukemia From the National Institutes of Health (National Cancer Institute)  
    Chronic Lymphocytic Leukemia/Diagnosis and Tests ... Chronic Lymphocytic Leukemia ... National Cancer Institute ... Chronic lymphocytic leukemia (CLL) treatment can include ...
    https://www.cancer.gov/types/leukemia/patient/cll-treatment-pdq#_24 - External Health Links
  5. General Information about Chronic Lymphocytic Leukemia From the National Institutes of Health (National Cancer Institute)  
    Chronic Lymphocytic Leukemia/Start Here ... Chronic Lymphocytic Leukemia ... National Cancer Institute ... From the National Institutes of Health ... Chronic lymphocytic ...
    https://www.cancer.gov/types/leukemia/patient/cll-treatment-pdq - External Health Links
  6. Advances in Lymphoma Research From the National Institutes of Health (National Cancer Institute)  
    Hodgkin Lymphoma/Statistics and Research ... Hodgkin Lymphoma ... Lymphoma/Statistics and Research ... Lymphoma ... National Cancer Institute ... From the National Institutes ...
    https://www.cancer.gov/types/lymphoma/research - External Health Links
  7. Drugs Approved for Non-Hodgkin Lymphoma From the National Institutes of Health (National Cancer Institute)  
    A list of cancer drugs approved by the Food and Drug Administration (FDA) for non-Hodgkin lymphoma. The list includes generic names, brand names, and common ...
    https://www.cancer.gov/about-cancer/treatment/drugs/non-hodgkin - External Health Links
  8. Treatment Option Overview (Adult Non-Hodgkin Lymphoma) From the National Institutes of Health (National Cancer Institute)  
    Non-Hodgkin lymphoma (NHL) options include chemotherapy, radiation, targeted therapy, plasmapheresis, surveillance, stem cell transplant, and surgery. ...
    https://www.cancer.gov/.../patient/adult-nhl-treatment-pdq#_190 - External Health Links
  9. Stages of Adult Non-Hodgkin Lymphoma From the National Institutes of Health (National Cancer Institute)  
    Non-Hodgkin lymphoma (NHL) options include chemotherapy, radiation, targeted therapy, plasmapheresis, surveillance, stem cell transplant, and surgery. ...
    https://www.cancer.gov/.../patient/adult-nhl-treatment-pdq#_158 - External Health Links
  10. General Information about Adult Non-Hodgkin Lymphoma From the National Institutes of Health (National Cancer Institute)  
    Lymphoma/Start Here ... Lymphoma ... National Cancer Institute ... Non-Hodgkin lymphoma (NHL) options include chemotherapy, radiation, targeted therapy, plasmapheresis, ...
    https://www.cancer.gov/.../patient/adult-nhl-treatment-pdq#_129 - External Health Links
previous · 1 · 2 · next